Prospective evaluation of the feasibility, safety, and efficacy of Cocoon Duct Occluder for transcatheter closure of large patent ductus arteriosus: A single-center study with short- and medium-term follow-up results

Hemolysis, embolization, obstruction of LPA or descending aorta, and death were not reported till D180.Conclusion: TCC using Cocoon Duct Occluder is feasible, safe, and effective in the management of patients with large PDA, with excellent results on short- and medium-term follow-up.

📌 3 Maddede Bu Makale

🎯

Amaç & Hipotez:Objective: To evaluate the feasibility, safety, and efficacy of a novel Cocoon Duct Occluder device for the transcatheter closure (TCC) of large patent ductus arteriosus (PDA).Methods: In this prospective, non-randomized study, consecutive patients with large PDA (narrowest diameter: >=3.5/4.0 mm in symptomatic/asymptomatic patients, respectively), who underwent TCC with Cocoon Duct Occluder at our institute between November, 2012 and June, 2016 were examined.

📊

Temel Bulgular & Veri:TCC was performed using the standard technique, and devices were antegradely delivered via 6-10F delivery sheaths.

💡

Sonuç & Katkı:Hemolysis, embolization, obstruction of LPA or descending aorta, and death were not reported till D180.Conclusion: TCC using Cocoon Duct Occluder is feasible, safe, and effective in the management of patients with large PDA, with excellent results on short- and medium-term follow-up.

🔬Tür:Araştırma Makalesi

📍Kapsam:2012 Verileri

⚙️Değişkenler:Alan Parametreleri

Abstract

Objective: To evaluate the feasibility, safety, and efficacy of a novel Cocoon Duct Occluder device for the transcatheter closure (TCC) of large patent ductus arteriosus (PDA).Methods: In this prospective, non-randomized study, consecutive patients with large PDA (narrowest diameter: >=3.5/4.0 mm in symptomatic/asymptomatic patients, respectively), who underwent TCC with Cocoon Duct Occluder at our institute between November, 2012 and June, 2016 were examined. TCC was performed using the standard technique, and devices were antegradely delivered via 6-10F delivery sheaths. Device embolization, residual shunt, hemolysis, left pulmonary artery (LPA) stenosis, procedural and fluoroscopy time, and mortality were assessed. Patients were followed-up by transthoracic echocardiography with color Doppler imaging at 24 h (D1), 1 month (D30), and 6 months (D180) after implantation.Results: A total of 57 patients (age: 11.7±2.8 years; weight: 22.3±3.5 kg) were enrolled. The mean narrowest diameter was 7.4±0.7 mm. The PDA closure was successfully performed in each patient. Fluoroscopy and procedural time was 6.7±3.2 min and 23.9±2.7 min, respectively. Postprocedural angiography revealed that 49 (85.9%) patients had immediate and complete closure, whereas 8 (14.1%) had residual shunt. Color Doppler imaging at D1 revealed complete closure in 52 (91.3%) patients. At D30, complete closure was reported in all patients and was maintained at D180. Hemolysis, embolization, obstruction of LPA or descending aorta, and death were not reported till D180.Conclusion: TCC using Cocoon Duct Occluder is feasible, safe, and effective in the management of patients with large PDA, with excellent results on short- and medium-term follow-up.

🔖

Bu Makaleye Atıf Yap

SİNHA, S. K., RAZİ, M., PANDEY, R. N., KUMAR, P., KRİSHNA, V., MİSHRA, V., ASİF, M., TEWARİ, P., THAKUR, R., PANDEY, U., VARMA, C. M. (2017). Prospective evaluation of the feasibility, safety, and efficacy of Cocoon Duct Occluder for transcatheter closure of large patent ductus arteriosus: A single-center study with short- and medium-term follow-up results. The Anatolian Journal of Cardiology, Cilt: 18 - Sayı: 5, 321–327. https://ajindex.com/articles/365822

📄 Tam Metin PDF Okuyucu

Yeni Sekmede Aç ↗

↗Yeni Sekme

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (4)

Mitchell SC, Korones SB, Berendes HW. Congenital heart disease in 56,109 births: incidence and natural history. Circulation 1971; 43: 323-32
Campbell M. Natural history of persistent ductus arteriosus. Br HeartJ 1968; 30: 4-13
Gaia DF, Palma JH, Kim HC, de Souza JA, Alves CR, Buffolo E. Patent ductus arteriosus: endovasculartreatment in adult patient. Arq Bras Cardiol 2008; 91: 25-7
Abdelbasit MA, Alwi M, Kandavello G, Che Mood M, Samion H, Hijazi ZM. The new Occlutech® PDA occluder: Initial human experience. Catheter Cardiovasc Interv 2015; 86: 94-9. Arora R, Kalra GS, Nigam M, Khalillulah M. Transcatheter occlusion of patent ductus arteriosus by Rashkind umbrella device: follow-up results. Am Heart 1994; 128: 539-41. Hijazi ZM, Geggel RL. Transcatheter closure of large patent ductus arteriosus (24 mm) With multiple Gianturco coils: immediate and midterm results. Heart 1996; 76: 536-40. Hijazi ZM, Lloyd TR, Beekman RH 3rd, Geggel RL. Transcatheter closure with single or multiple Gianturco coils of patent ductus arteriosus in infants weighing or:8 kg: retrograde versus antegrade approach. Am HeartJ 1996; 132: 827-35. Moore JVV, George L, Kirkpatrick SE, Mathewson JW, Spicer RL, Uzark K, et al. Percutaneous closure of the small patent ductus arteriosus using occluding spring coils. Am Coll Cardiol 1994; 23: 759-65. Bilkis AA, Alwi M, Hasri S, Haifa AL, Geetha K, Rehman MA, et al. The Amplatzer duct occluder: experience in 209 patients. Am Coll Cardiol 2001; 37: 258-61. Thanopoulos BD, Tsaousis GS, Djukic M, Al Hakim F, Eleftherakis NG, Simeunovic SD. Transcatheter closure of high pulmonary pressure persistent ductus arteriosus with Amplatzer muscular ventricular septal defect occluder. Heart 2002; 87: 260-3. Krichenko A, Benson LN, Burrows Moes CA, McLaughlin P, Freedom RM. Angiographic classification of the isolated, persistently patent ductus arteriosus and implications for percutaneous catheter occlusion. Am Cardiol 1989; 63: 877-80. Schneider DJ, Moore JW. Patent ductus arteriosus. Circulation 2006; 114: 1873-82. Atiq M, Aslam N, Kazmi KA. Transcatheter closure of small-to large patent ductus arteriosus with different devices: queries and challenges. lnvasive Cardiol 2007; 19: 295-8. Thanopoulos BD, Hakim FA, Hiari A, Tsaousis GS, Paphitis C, Hijazi ZM. Patent ductus arteriosus equipment and technique, Amplatzer duct occluder: intermediate-term follow-up and technical considerations. Interv Cardiol 2001; 14: 247-54. Yang SW, Zhou YJ, Hu